Vujkovic-Cvijin, I. http://orcid.org/0000-0002-8611-4900
Sortino, O.
Verheij, E.
Sklar, J.
Wit, F. W. http://orcid.org/0000-0003-2066-8115
Kootstra, N. A.
Sellers, B.
Brenchley, J. M.
Ananworanich, J. http://orcid.org/0000-0003-1369-3224
Loeff, M. Schim van der
Belkaid, Y. http://orcid.org/0000-0001-9962-3571
Reiss, P. http://orcid.org/0000-0001-7896-6428
Sereti, I. http://orcid.org/0000-0002-0076-0224
Article History
Received: 1 December 2019
Accepted: 15 April 2020
First Online: 15 May 2020
Competing interests
: PR reports independent scientific grant support from Gilead Sciences, Merck & Co, and ViiV Healthcare through his institution; scientific advisory board participation for Gilead Sciences, ViiV Healthcare, Merck & Co., and Teva Pharmaceutical Industries Ltd., for which his institution has received remuneration. The remaining authors declare no competing interests.